Glutamatergic agents for the treatment of cognitive impairments in patients with schizophrenia

被引：0
|
作者：
Buchanan, RW [1 ]
Gold, JM [1 ]
Bilder, R [1 ]
Green, M [1 ]
Javitt, DC [1 ]
Marder, SR [1 ]
Schooler, NR [1 ]
Heresco-Levy, U [1 ]
McMahon, RP [1 ]
Carpenter, WT [1 ]
机构：
[1] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA
来源：
SCHIZOPHRENIA BULLETIN | 2005年 / 31卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：477 / 477
页数：1
相关论文
共 50 条
  • [31] Probing the cognitive, clinical, and functional impairments of schizophrenia patients with mismatch negativity
    Light, GA
    Meyer-Gomes, K
    Sprock, J
    Braff, DL
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S198 - S198
  • [32] MMN deficits are associated with cognitive, clinical, and functional impairments in schizophrenia patients
    Light, GA
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 210S - 210S
  • [33] Novel glutamatergic treatment approaches for schizophrenia
    Javitt, DC
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S26 - S26
  • [34] TREATMENT WITH GLUTAMATERGIC DRUGS IN THE RESISTANT SCHIZOPHRENIA
    de Velasco Soriano, R. Martinez
    Pando Velasco, F.
    Serrano Diaz de Otalora, M.
    Artieda Urrutia, P.
    Riaza Bermudo-Soriano, C.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [35] Impairments to Cognitive Control in Patients with Somatoform Disorders and Their Treatment
    Chutko L.S.
    Surushkina S.Y.
    Yakovenko E.A.
    Anisimova T.I.
    Karpovskaya E.B.
    Vasilenko V.V.
    Didur M.D.
    Volov M.B.
    Neuroscience and Behavioral Physiology, 2020, 50 (2) : 162 - 167
  • [36] GLUTAMATERGIC DYSFUCTION AND TREATMENT RESPONSE IN MINIMALLY TREATED AND CHRONIC SCHIZOPHRENIA PATIENTS
    Mouchlianitis, Elias
    Vanes, Lucy
    Barry, Erica
    Patel, Krisna
    Wong, Katie
    Porfy, Lilla
    Shergill, Sukhi
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S92 - S93
  • [37] The prevalence of specific cognitive impairments in schizophrenia.
    Squibb, SM
    Evans, JD
    Palmer, BW
    Paulsen, JS
    Jeste, DV
    Heaton, RK
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 1997, 12 (04) : 409 - 409
  • [38] Fluvoxamine improved cognitive impairments in a patient with schizophrenia
    Niitsu, Tomihisa
    Shirayama, Yukihiko
    Fujisaki, Mihisa
    Hashimoto, Kenji
    Iyo, Masaomi
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (07): : 1345 - 1346
  • [39] Cognitive impairments, emotion, stress, and language in schizophrenia
    Seghers, James P.
    Docherty, Nancy M.
    PSYCHIATRY RESEARCH, 2009, 170 (2-3) : 97 - 102
  • [40] Montreal Cognitive Assessment as a screening instrument for cognitive impairments in schizophrenia
    Yang, Zixu
    Rashid, Nur Amirah Abdul
    Quek, Yue Feng
    Lam, Max
    See, Yuen Mei
    Maniam, Yogeswary
    Dauwels, Justin
    Tan, Bhing Leet
    Lee, Jimmy
    SCHIZOPHRENIA RESEARCH, 2018, 199 : 58 - 63
12345